These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 15671554

  • 1. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y, Sui L, Watanabe Y, Yamaguchi F, Hatano N, Tokuda M.
    Clin Cancer Res; 2005 Jan 01; 11(1):259-66. PubMed ID: 15671554
    [Abstract] [Full Text] [Related]

  • 2. Significance of Jab1 expression in human esophageal squamous cell carcinoma.
    Wang F, Wang Y, Yu X, Yang D, Wang Z, Lu C, Yuan Z, Xiao M, Shen A.
    J Clin Gastroenterol; 2009 Jul 01; 43(6):520-6. PubMed ID: 19349901
    [Abstract] [Full Text] [Related]

  • 3. S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications.
    Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M.
    Oncol Rep; 2003 Jul 01; 10(2):321-5. PubMed ID: 12579266
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Fukumoto A, Ikeda N, Sho M, Tomoda K, Kanehiro H, Hisanaga M, Tsurui Y, Tsutsumi M, Kato JY, Nakajima Y.
    Oncol Rep; 2004 Feb 01; 11(2):277-84. PubMed ID: 14719054
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y, Tokuda M.
    Clin Cancer Res; 2001 Dec 01; 7(12):4130-5. PubMed ID: 11751512
    [Abstract] [Full Text] [Related]

  • 7. High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
    Harada K, Kawashima Y, Yoshida H, Sato M.
    Anticancer Res; 2006 Dec 01; 26(2B):1615-9. PubMed ID: 16619581
    [Abstract] [Full Text] [Related]

  • 8. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.
    Ito Y, Yoshida H, Matsuzuka F, Matsuura N, Nakamura Y, Nakamine H, Kakudo K, Kuma K, Miyauchi A.
    Anticancer Res; 2003 Dec 01; 23(5b):4121-5. PubMed ID: 14666612
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY, Ryu YS, Chung MS, Kim KD, Park SS, Chae SK, Chae HZ, Kwon KS.
    Oncogene; 2004 Nov 25; 23(55):8868-75. PubMed ID: 15480426
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas.
    Dong Y, Sui L, Tai Y, Sugimoto K, Hirao T, Tokuda M.
    Clin Cancer Res; 2000 Nov 25; 6(11):4253-8. PubMed ID: 11106240
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A, Yoshino I, Kometani T, Yamaguchi M, Kameyama T, Yohena T, Maehara Y.
    Cancer; 2006 Jul 01; 107(1):154-61. PubMed ID: 16721818
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct 01; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low p27Kip1 expression is associated with poor prognosis in oral squamous cell carcinoma.
    Harada K, Supriatno, Yoshida H, Sato M.
    Anticancer Res; 2002 Oct 01; 22(5):2985-9. PubMed ID: 12530030
    [Abstract] [Full Text] [Related]

  • 18. p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.
    Masciullo V, Ferrandina G, Pucci B, Fanfani F, Lovergine S, Palazzo J, Zannoni G, Mancuso S, Scambia G, Giordano A.
    Clin Cancer Res; 2000 Dec 01; 6(12):4816-22. PubMed ID: 11156240
    [Abstract] [Full Text] [Related]

  • 19. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK.
    Int J Oncol; 2003 Feb 01; 22(2):409-14. PubMed ID: 12527941
    [Abstract] [Full Text] [Related]

  • 20. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.
    Kuczyk M, Machtens S, Hradil K, Schubach J, Christian W, Knüchel R, Hartmann J, Bokemeyer C, Jonas U, Serth J.
    Br J Cancer; 1999 Nov 01; 81(6):1052-8. PubMed ID: 10576664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.